MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11060-024-04618-1

Медицинская библиотека · Journal of neuro-oncology · 2024

A new updated prognostic index for patients with brain metastases (BMs) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology. METASNCore project.

Flores-Paco Pablo, Vargas-Aliaga Alicia, Guevara María Geraldina, Lopera Ignacio, Ruiz Lucía Rodríguez, López-Herrero María, Camús Juan Adrián, López-González Javier, Inga-Saavedra Elizabeth, Montero Marina, Barneto Isidoro, Gómez-España Mª Auxiliadora, Ruiz Estela, Ruza Marta, Armenta Ana, Palacios Amalia, De La Haba-Rodríguez Juan R, Aranda Enrique

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Palliative WBRT is the main treatment for multiple BMs. Recent studies report no benefit in survival after WBRT compared to palliative supportive care in patients (pts) with poor prognosis. A new era of systemic treatment strategies based on targeted therapies are improving the prognosis of patients with BMs. The purpose of this study is to develop a prognostic score in palliative pts with BMs who undergo WBRT in this new setting.

METHODS

239 pts with BMs who received palliative WBRT between 2013-2022 in our center were analyzed retrospectively. The score was designed according to the value of the β coefficient of each variable with statistical significance in the multivariate model using Cox regression. Once the score was established, a comparison was performed according to Kaplan-Meier and was analyzed by log-rank test.

RESULTS

149 pts (62.3%) were male and median (m) age was 60 years. 139 (58,2%) were lung cancer and 35 (14,6%) breast cancer. All patients received 30Gys in 10 sessions. m overall survival (OS) was 3,74 months (ms). 37 pts (15,5%) had a specific target mutation. We found that 62 pts were in group < 4 points with mOS 6,89 ms (CI 95% 3,18-10,62), 84 in group 4-7 points with mOS 4,01 ms (CI 95% 3,40-4,62) and 92 pts in group > 7 points with mOS 2,72 ms (CI 95% 1,93-3,52) (p < 0,001).

CONCLUSIONS

METASNCore items are associated with OS and they could be useful to select palliative pts to receive WBRT. More studies are necessary to corroborate our findings.

Для цитирования: Flores-Paco Pablo, Vargas-Aliaga Alicia, Guevara María Geraldina, Lopera Ignacio, Ruiz Lucía Rodríguez, López-Herrero María, Camús Juan Adrián, López-González Javier, Inga-Saavedra Elizabeth, Montero Marina, Barneto Isidoro, Gómez-España Mª Auxiliadora, Ruiz Estela, Ruza Marta, Armenta Ana, Palacios Amalia, De La Haba-Rodríguez Juan R, Aranda Enrique. A new updated prognostic index for patients with brain metastases (BMs) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology. METASNCore project.. Journal of neuro-oncology. 2024. DOI: 10.1007/s11060-024-04618-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.